Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.
Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C. Mayer M, et al. Among authors: quaas a. Eur Arch Otorhinolaryngol. 2024 Apr 8. doi: 10.1007/s00405-024-08627-8. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38587651
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patients.
Klein S, Wuerdemann N, Demers I, Kopp C, Quantius J, Charpentier A, Tolkach Y, Brinker K, Sharma SJ, George J, Hess J, Stögbauer F, Lacko M, Struijlaart M, van den Hout MFCM, Wagner S, Wittekindt C, Langer C, Arens C, Buettner R, Quaas A, Reinhardt HC, Speel EJ, Klussmann JP. Klein S, et al. Among authors: quaas a. NPJ Digit Med. 2023 Aug 19;6(1):152. doi: 10.1038/s41746-023-00901-z. NPJ Digit Med. 2023. PMID: 37598255 Free PMC article.
Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks.
Pisula JI, Datta RR, Valdez LB, Avemarg JR, Jung JO, Plum P, Löser H, Lohneis P, Meuschke M, Dos Santos DP, Gebauer F, Quaas A, Walch A, Bruns CJ, Lawonn K, Popp FC, Bozek K. Pisula JI, et al. Among authors: quaas a. Br J Cancer. 2023 Mar;128(7):1369-1376. doi: 10.1038/s41416-023-02143-y. Epub 2023 Jan 30. Br J Cancer. 2023. PMID: 36717673 Free PMC article.
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial.
Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Alexandersson von Döbeln G, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M. Nilsson K, et al. Among authors: quaas a. Ann Oncol. 2023 Nov;34(11):1015-1024. doi: 10.1016/j.annonc.2023.08.010. Epub 2023 Aug 30. Ann Oncol. 2023. PMID: 37657554 Free article. Clinical Trial.
Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis.
Schlachtenberger G, Schallenberg S, Doerr F, Menghesha H, Gaisendrees C, Amorin A, Grathwohl C, Büttner R, Quaas A, Horst D, Klauschen F, Frost N, Rueckert JC, Neudecker J, Höpker K, Wahlers T, Hekmat K, Heldwein MB. Schlachtenberger G, et al. Among authors: quaas a. Eur J Cardiothorac Surg. 2023 Jul 3;64(1):ezad247. doi: 10.1093/ejcts/ezad247. Eur J Cardiothorac Surg. 2023. PMID: 37369037
308 results